• Home
  • CML Experts
    • Team of experts on CML who developed imatinib>
      • Dr. Elisabeth Buchdunger
      • Dr. Brian Druker
      • Dr. John Goldman
      • Dr. Nora C. Heisterkamp
      • Dr. David Hungerford
      • Dr. Nicholas Lydon
      • Dr. Felix Mitelman
      • Dr. Peter C. Nowell
      • Dr. Carlo Gambacorti-Passerini
      • Dr. Moshe Talpaz
      • Dr. Janet D. Rowley
      • Dr. Charles Sawyers
      • Dr. Jürg Zimmermann
      • Dr. Owen Witte
    • Experts involved in developing nilotinib>
      • Dr. Frank Giles
    • Experts involved in developing dasatinib>
      • Dr. Jagabandhu Das
    • Other CML experts in America>
      • Other CML experts in Canada>
        • Dr. Sarit Assouline
        • Dr. Lambert Busque
        • Dr. Robert Delage
        • Dr. Josée Hébert
        • Dr. Pierre Laneuville
        • Dr. Jeffrey H Lipton
        • Dr. Luigina Mollica
      • Other CML experts in US>
        • Carolyn Blasdel, RN , FNP-BC, OCN
        • PATRICIA JAKEL, RN, MN, AOCN
        • Rey Garcia, RN, BSN
        • Dr. Jorge E. Cortes
        • Dr. Arul Chinnaiyan
        • Dr. Michael Deininger
        • Dr. James D. Griffin
        • Dr. Elias J. Jabbour
        • Dr. Hagop Kantarjian
        • Dr. Richard A. Larson
        • Dr. Alison Loren
        • Dr. Michael Mauro
        • Dr. Stephen D. Nimer
        • Dr. Ruben A. Mesa
        • Dr. Susan M. O'Brien
        • Dr. Jerald P. Radich
        • Dr. Karen Seiter
        • Dr. Neil Shah
        • Dr. Richard Stone
        • Dr. Raoul Tibes
        • Dr. Bin Zhang
    • Other CML Experts in Europe>
      • Dr. Jane Apperley
      • Dr. Michele Baccarani
      • Pr. Agnès Buzyn
      • Dr. Gabriel Etienne
      • Dr. François Guilhot
      • Dr. Eliane Gluckman
      • Dr. Andreas Hochhaus
      • Dr. Tessa L Holyoake
      • Dr. Hana Klamova
      • Dr. Jeroen J.W.M. Janssen
      • Dr. Franck-Emmanuel Nicolini
      • Dr. Delphine Rea
      • Dr. Johan Richter
      • Dr. Philippe Rousselot
      • Dr. Giuseppe Saglio
      • Dr. François-Xavier Mahon
    • Other CML experts in Asia>
      • Dr. Charles Chuah
      • Dr. Goh Yeow Tee
      • Dr. Pankaj Malhotra
      • Dr. Kim Dong-Wook
    • Other CML experts in Australia>
      • Dr. Susan Branford
      • Pr Tim Hughes
      • Dr. Anthony P Schwarer
  • Medical Concepts
    • Introduction to CML
    • Blood
    • DNA
    • Immune System>
      • Natural killer cell - NK
      • T Cells
    • JAK2 Gene
    • Polymerase Chain Reaction
    • Stem Cells
    • Donor lymphocyte infusion (DLI)
    • Myeloproliferative disorders (MPD)>
      • Chronic Myeloid Leukemia (CML)
      • Essential Thrombocythemia (ET)
      • Myelofibrosis (MF)
      • Polycythemia Vera (PV)
    • Types of leukemia
  • Medication
    • Hydroxyurea
    • Interferon Alpha
    • Gleevec (Imatinib)
    • Tasigna (Nilotinib)
    • Sprycel (Dasatinib)
    • (Bosutinib)
    • (Ponatinib)
    • Supect (Radotinib)
  • Managing side effects
    • List of side effets>
      • Bone Pain
      • Depression
      • Eyes
      • Ear
      • Fatigue
      • Fluid Retention
      • Gastrointestinal system
      • Hair
      • Heart
      • Kidney
      • Muscle cramping
      • Skin
    • Art Therapy>
      • Art Therapist
      • CMLer's portofolio
    • Massage therapy
    • Music therapy>
      • YouTube creation by CMLer's family
      • Magnificent (I Believe)
    • Physical Activity
    • Psycho-Oncology
    • Professionnel help and literature
    • Yoga
    • Zootherapy
  • Patient Testimonials
    • Gary Gonzales
    • Pat Elliott
    • Rob Shick
    • Virginia Garner
    • Laura Boyd
    • Drew Johnston
    • Royston Hogan
    • Doug Jenson
    • Rich Jones
    • Kevin Williams
    • Jan Geissler
    • Jean McGlynn
    • Tamera Simonson
    • Hans Loland
    • Christopher
    • Alexa Score
    • Others testimonials
    • Some celebrities>
      • Tim Holcomb
      • Doris Muramatsu
      • Ryan O'Neal
      • Kareem Abdul-Jabar
      • Jason Blake
      • Rick Upchurch
    • Bud Romine - the first patient
    • Kayla Naton (Pregnancy)
    • Suzan Mc Namara and the petition
  • Blogs
    • Trey's CML Leukemia Blog
    • Living with CML
    • CMKID's blog – Dislodging the bullet
    • CML Recovery - Stopping KTI
    • Hans's Blog
    • David's Blog
    • Elizabeth's Blog - my leukemia journey
    • Elizabeth's Blog - Heart of the rose
    • Donna C's Blog
    • Ian's Blog
    • Joe's Blog
    • Jon's Blog
    • Josh's Blog
    • Lisa's Blog
    • Matt's Blog
    • Matthew's Blog
    • Michelle's Blog
    • Michelle D's Blog
    • Nayree's Blog
    • Rob's Blog
  • News on CML (Chronic myeloid leukemia)
    • English
    • French (Français)
    • Spanish (Español)
  • Various topics
    • You’ve just been diagnosed
    • History of CML
    • CML causes
    • Food and Drug Interactions
    • Bone marrow transplant
    • Stem cells from umbilical cord blood
    • Children with CML
    • CML and pregnancy
    • Elderly patients with CML
    • Cure possible for CML?
    • CML vaccine
    • Feverfew extract (parthenolide)
    • Possible cure for CML in Fish Oil
    • Can dandelions kill cancer?
    • The French trial called STIM (Stop Imatinib)
    • Math could help cure leukemia
    • Mutation T315I
    • Sports with CML
    • CML Awareness Day
  • Congresses, conferences, meetings ASH, ASCO, EHA ...
    • ASCO 2012 - Chicago
    • ASCO 2011 - Chicago
    • ASCO 2010 - Chicago
    • ASH 2011 - San Diego
    • ASH 2010 - Orlando
    • ASH 2009 - New Orleans
    • BTG 2011 - Singapore (Singapore)
    • EHA 2011 - London (England)
    • EHA 2010 - Cascais (Portugal)
    • EHA 2009 - Berlin (Germany)
    • EHA 2008 - Copenhague (Danemark)
    • NHSM 2011 (Bergen, Norway)
    • NHSM 2010 (Uppsala, Sweden)
  • Moral Support
    • Family support
    • The march toward healing
    • Be happy
    • I Had Cancer: You are not alone
    • Where to get help and support
    • Dances at the Cancer Research Centre
    • Magnificent - Beauty of nature
  • Patient Rights
  • Links to other sites, forums and Facebook
    • Sites ( English and other languages)
    • Forums
    • CML on Facebook
    • CML on Twitter
    • Audio Podcast
  • Specialist Journals in Hematology/Oncology
  • International publications
    • Publications from Africa
    • Publications from America
    • Publications from Australia
    • Publications from Asia
    • Publications from Europe
  • Foundations
    • Leukemia Foundations>
      • American Cancer Society
    • Hospital Foundations
  • CML Glossaries
  • Educational events
  • Educational videos
    • Educational videos (in English)
    • Educación de vídeos en español (in Spanish)
    • Vidéos pédagogiques en français (in French)
  • About us
  • Guestbook
  • Comments

Chronic Myeloid Leukemia

 

Mutation T315I -   Chronic Myeloid Leukemia-      CML


CLINICAL TRIAL DRUGS

AP24534 - Ponatinib by Ariad
Omacetaxine by
ChemGenex
DCC-2036 and DCC- 2157 by Deciphera
KW-2449 by Kyowa Hakko Kirin Pharma, Inc

                  
AACR 2012: Promising CML & PI3K compounds from Indian company Piramal Healthcare (P2745 - T315i mutation)

April 24, 2012,Biotech Strategy Blog
Novel potent inhibitor (P2745) of Bcr-Abl mutated imatinib resistant chronic myeloid leukemia cell lines (included
T315I)

April 2, 2012, AACR Annual Meeting 2012
Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa.
January 20, 2012, International Journal of Hematology

A clinical Trial ( Mutation T315I) and a Growing Family - Hans Loland                                                  VIDEO
November 18, 2011,
Patient Power

Treatment of chronic phase (CP) chronic myeloid leukemia (CML) patients who harbour the BCR-ABL T315I mutation with subcutaneous omacetaxine results in improved survival compared to historical data
June 12 2011, EHA 2011

A pyrosequencing-based test for detection and relative quantification of the BCR-ABL1 T315I point mutation
April 12, 2011,  Journal of clinical pathology

Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036
April 12, 2011, Cancer cell

Ariad, MolecularMD To Develop Diagnostic Test For CML Patients
April 6, 2011, Clinical Lab Products

Ariad, MolecularMD Partner on Companion Dx for T315I Mutation
March 28, 2011,  genomeweb

Phase I Trial Shows Ponatinib May Thwart Most Resistant CML
December 16, 2010,  MD Anderson Cancer Center - Department of Leukemia

Targeting the BCR-ABL Signaling Pathway in Therapy-Resistant Philadelphia Chromosome-Positive Leukemia
November 17, 2010, Clinical Cancer Research

The ABL Switch Control Inhibitor DCC-2036 Is Active against the Chronic Myeloid Leukemia Mutant BCR-ABLT315I and Exhibits a Narrow Resistance Profile
November 15, 2010,  Cancer Research

KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutatedBCR/ABL translocation
May 28, 2009, Journal Blood

ChemGenex's Omacetaxine Demonstrates 80% Complete Hematological Response Rate In Drug-Resistant CML Patients With The T315I Mutation
December 10, 2008,  Medical News Today

Complete Suppression of in Vitro Resistance by AP24534, a Pan-BCR-ABL Inhibitor
December 8, 2008, ASH2008

Therapeutic Options Against BCR-ABL1 T315I-Positive Chronic Myelogenous Leukemia
March 6, 2008, Clinical Cancer Research

                  












Create a free website with Weebly